Nvidia, Apple, and Eli Lilly: Manufacturing the Future

Motley Fool Money

The great buildout for AI and GLP-1 drugs continues.


(00:21) Jason Moser and Matt Argersinger discuss:


- How Nvidia continues to deliver in the face of great expectations, but even those great results haven’t kept the market happy with the chipmaker or big tech stocks to start 2025.

- Apple and Eli Lilly’s plans to expand manufacturing and development in the U.S.

- Earning updates from Home Depot, Axon, and Cava.


Here is Jason’s fabled at-home Cava recipe: https://moribyan.com/spicy-lamb-meatballs-cava-copycat/


(19:11) Jason dives deeper into Axon’s earnings with President Josh Isner, breaking down some of the major growth opportunities ahead, and how the company is approaching the focus on government budgets and tariff talks.


(34:53) Matt and Jason break down two stocks on their radar: Marqueta and EPR Properties.


Stocks discussed: NVDA, AAPL, LLY, HD, AXON, CAVA, MQ, EPR


Host: Dylan Lewis

Guests: Jason Moser, Matt Argersinger, Josh Isner

Engineers: Dan Boyd, Rick Engdahl

Learn more about your ad choices. Visit megaphone.fm/adchoices

2025-02-28 40 min

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in

Chapters

No chapters available.